Since CD163+ TAMs are activated by anti-PD1 antibody (29), the TAM-related chemokines such as sCD163 and CXCL5 are important to evaluate the recruitment of anti-PD1 antibody in the tumor microenvironment. The gene discussed is CXCL5; the disease is neoplasm.